Viridian Therapeutics (1S1.F) Q1 2025 Earnings

Feb 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.08
-0.97
-0.85
-0.73

Details

Expected EPS
-0.9955829439999999
Actual EPS
-0.778896
Surprise EPS
0.22
Surprise Percent
+21.76%

Description

⁨Viridian Therapeutics⁩ (⁦1S1.F⁩) has reported earnings of ⁦-0.778896⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts